Oleg Shvets

Oleg Shvets
  • Tallinn University of Technology

About

27
Publications
5,876
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
590
Citations
Current institution

Publications

Publications (27)
Article
Full-text available
Background & Aims Antibiotic resistance is one of the main factors that determines the efficacy of treatments to eradicate Helicobacter pylori ( H. pylori ) infection. Our aim was to evaluate the effectiveness of first-line and rescue treatments against H. pylori in Europe according to antibiotics resistance. Methods Prospective, multicenter, inte...
Article
Full-text available
BACKGROUND & AIMS After a first Helicobacter pylori eradication attempt, approximately 20% of patients will remain infected. The aim of current study was to assess the effectiveness and safety of second-line empirical treatment in Europe. METHODS This international, multicenter, prospective non-interventional Registry aimed to evaluate the decisio...
Article
Introduction: The safety of Helicobacter pylori eradication treatments and to what extent adverse events (AEs) influence therapeutic compliance in clinical practice are hardly known. Our aim was to assess the frequency, type, intensity, and duration of AEs, and their impact on compliance, for the most frequently used treatments in the "European Re...
Article
Full-text available
Objective: The best approach for Helicobacter pylori management remains unclear. An audit process is essential to ensure clinical practice is aligned with best standards of care. Design: International multicentre prospective non-interventional registry starting in 2013 aimed to evaluate the decisions and outcomes in H. pylori management by Europ...
Article
Full-text available
Background: Experience in Helicobacter pylori eradication treatment of patients allergic to penicillin is very scarce. A triple combination with a PPI, clarithromycin (C), and metronidazole (M) is often prescribed as the first option, although more recently the use of a quadruple therapy with PPI, bismuth (B), tetracycline (T), and M has been reco...
Article
Background: In collaboration with United European Gastroenterology, the working group on 'Harmonizing diagnosis and treatment of chronic pancreatitis across Europe' (HaPanEU) developed European guidelines for the management of chronic pancreatitis using an evidence-based approach. Methods: Recommendations of multidisciplinary review groups based...

Network

Cited By